Patent · US Active

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

US9295732B2 · kind B2 · utility

23Cited by

1References

4Claims

0Family size

Assignee

INVIVOGEN · FR

Inventors

Thierry Lioux · Balma, FR
Daniel Drocourt · Toulouse, FR
Fabienne Vernejoul · Toulouse, FR
Gerard Tiraby · Toulouse, FR
Eric Perouzel · Toulouse, FR

Key dates

Filing date	Feb 22, 2013
Grant date	Mar 29, 2016
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/542
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A conjugated compound of Formula I: Q-Z—R4 wherein Q is a TLR7 and/or TLR8 agonist and Z—R4 is a TLR2 agonist, the conjugated compound being chosen among compounds of Formula II:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.